VUNO

VUNO is a South Korean medical AI company and developer of the nation's first approved AI-powered medical device, founded in 2014 in Seoul. The company's core products — VUNO Med-Chest X-ray, VUNO Med-Fundus AI, and VUNO Med-DeepCARS — provide AI-driven analysis of medical imaging (CT, X-ray, MRI), pathology slides, biosignals (ECG, vital signs), and retinal imaging to assist clinicians in diagnosing thoracic abnormalities, retinal diseases, and cardiac arrest risk. VUNO Care-HATIV extends the platform to personal chronic disease management. The company holds CE Mark for five solutions and serves hospital networks across Asia and the Middle East, with growing international export revenue. VUNO is publicly listed on the KOSDAQ exchange (338220.KQ) and has ISO/IEC 27001 and 27701 certifications.